Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma
Open Access
- 1 October 2008
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 10 (5), 675-689
- https://doi.org/10.1215/15228517-2008-036
Abstract
Pediatric ependymomas are enigmatic tumors, and their clinical management remains one of the more difficult in pediatric oncology. The identificationThis publication has 66 references indexed in Scilit:
- Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective studyThe Lancet Oncology, 2007
- Inactivation of nucleolin leads to nucleolar disruption, cell cycle arrest and defects in centrosome duplicationBMC Molecular Biology, 2007
- Cell Cycle-controlled Interaction of Nucleolin with the Retinoblastoma Protein and Cancerous Cell TransformationPublished by Elsevier BV ,2006
- The Role of Telomere Maintenance in the Spontaneous Growth Arrest of Pediatric Low-Grade GliomasNeoplasia, 2006
- The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical eraCancer, 2004
- Telomere maintenance in childhood primitive neuroectodermal brain tumorsNeuro-Oncology, 2004
- Pediatric Intracranial Ependymomas: Prognostic Relevance of Histological, Immunohistochemical, and Flow Cytometric FactorsLaboratory Investigation, 2003
- A Multi-Institutional Retrospective Study of Intracranial Ependymoma in ChildrenJournal of Pediatric Hematology/Oncology, 1999
- A survey of telomerase activity in human cancerEuropean Journal of Cancer, 1997
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994